Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainHMG_box_2

SP100 HMGB1 HMGB3

6.48e-069813PF09011
Domain-

AP2A1 AP2A2

1.86e-0528122.60.40.1030
DomainAP2_complex_asu

AP2A1 AP2A2

1.86e-052812IPR017104
DomainClathrin_a-adaptin_app_sub_C

AP2A1 AP2A2

1.86e-052812IPR003164
DomainClathrin_a-adaptin_app_Ig-like

AP2A1 AP2A2

1.86e-052812IPR013038
DomainAlpha_adaptin_C

AP2A1 AP2A2

1.86e-052812PF02296
DomainHMG_boxA_CS

HMGB1 HMGB3

5.56e-053812IPR017967
Domain-

AP2A1 AP2A2

1.11e-0448123.30.310.30
DomainClathrin_a/coatomer_app_sub_C

AP2A1 AP2A2

1.11e-044812IPR015873
DomainRhoGAP

MYO9A MYO9B RALBP1 ARAP2

1.51e-0462814SM00324
DomainRhoGAP

MYO9A MYO9B RALBP1 ARAP2

1.61e-0463814PF00620
DomainRHOGAP

MYO9A MYO9B RALBP1 ARAP2

1.71e-0464814PS50238
DomainRhoGAP_dom

MYO9A MYO9B RALBP1 ARAP2

1.71e-0464814IPR000198
Domain-

MYO9A MYO9B RALBP1 ARAP2

1.71e-04648141.10.555.10
DomainCa/CaM-dep_Ca-dep_prot_Kinase

DAPK3 DCLK2 EFHB DCLK1

2.29e-0469814IPR020636
DomainDCX

DCLK2 DCLK1

2.76e-046812SM00537
Domain-

DCLK2 DCLK1

3.85e-0478123.10.20.230
DomainDCX

DCLK2 DCLK1

3.85e-047812PF03607
DomainRA

MYO9A MYO9B ARAP2

5.06e-0436813PF00788
DomainCoatomer/calthrin_app_sub_C

AP2A1 AP2A2

5.11e-048812IPR009028
DomainDC

DCLK2 DCLK1

5.11e-048812PS50309
DomainDoublecortin_dom

DCLK2 DCLK1

5.11e-048812IPR003533
DomainRA

MYO9A MYO9B ARAP2

5.49e-0437813PS50200
DomainRho_GTPase_activation_prot

MYO9A MYO9B RALBP1 ARAP2

5.81e-0488814IPR008936
DomainClathrin_a/b/g-adaptin_app_Ig

AP2A1 AP2A2

6.56e-049812IPR008152
DomainAlpha_adaptinC2

AP2A1 AP2A2

6.56e-049812PF02883
DomainAlpha_adaptinC2

AP2A1 AP2A2

6.56e-049812SM00809
DomainRA_dom

MYO9A MYO9B ARAP2

6.92e-0440813IPR000159
DomainHMG_BOX_1

HMGB1 HMGB3

8.17e-0410812PS00353
DomainSer/Thr_kinase_AS

STK10 MYLK CDK12 DAPK3 DCLK2 WNK1 DCLK1

9.09e-04357817IPR008271
DomainS_TKc

STK10 MYLK CDK12 DAPK3 DCLK2 WNK1 DCLK1

9.39e-04359817SM00220
DomainPROTEIN_KINASE_ST

STK10 MYLK CDK12 DAPK3 DCLK2 WNK1 DCLK1

9.86e-04362817PS00108
DomainCoatomer/clathrin_app_Ig-like

AP2A1 AP2A2

1.19e-0312812IPR013041
DomainPkinase

STK10 MYLK CDK12 DAPK3 DCLK2 WNK1 DCLK1

1.32e-03381817PF00069
DomainHMG_box

SP100 HMGB1 HMGB3

1.57e-0353813PF00505
DomainHMG_BOX_2

SP100 HMGB1 HMGB3

1.66e-0354813PS50118
DomainHMG

SP100 HMGB1 HMGB3

1.66e-0354813SM00398
Domain-

SP100 HMGB1 HMGB3

1.75e-03558131.10.30.10
DomainClathrin/coatomer_adapt-like_N

AP2A1 AP2A2

1.88e-0315812IPR002553
DomainAdaptin_N

AP2A1 AP2A2

1.88e-0315812PF01602
DomainHMG_box_dom

SP100 HMGB1 HMGB3

2.83e-0365813IPR009071
DomainRRM_dom

LARP4B DNAJC17 HTATSF1 HNRNPAB SYNCRIP

3.07e-03227815IPR000504
DomainRRM

LARP4B DNAJC17 HTATSF1 HNRNPAB SYNCRIP

3.25e-03230815PS50102
Domain-

TRAP1 SACS

3.36e-03208123.30.565.10
DomainIQ

MYO9A MYO9B ASPM

3.63e-0371813PF00612
DomainHATPase_C

TRAP1 SACS

3.70e-0321812IPR003594
DomainPROTEIN_KINASE_ATP

STK10 MYLK CDK12 DAPK3 DCLK2 WNK1 DCLK1

3.76e-03459817PS00107
Domain-

LARP4B DNAJC17 HTATSF1 HNRNPAB SYNCRIP

4.18e-032448153.30.70.330
DomainIQ

MYO9A MYO9B ASPM

5.26e-0381813SM00015
DomainNucleotide-bd_a/b_plait

LARP4B DNAJC17 HTATSF1 HNRNPAB SYNCRIP

5.28e-03258815IPR012677
DomainProt_kinase_dom

STK10 MYLK CDK12 DAPK3 DCLK2 WNK1 DCLK1

5.30e-03489817IPR000719
PathwayREACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION

AP2A1 AP2A2 MYLIP

5.50e-0516673M27761
PathwayREACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION

AP2A1 AP2A2 MYLIP

5.50e-0516673MM15506
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

KRT3 SP100 TRAP1 BCAP31 ZMPSTE24 MYLK BRCA1 AP2A1 AP2A2 SACS UGGT1 STRN4 ASPM HMGB1 SRP72 HMGB3 MYOM2 MPHOSPH10 STOX1 PPIP5K2 NEB HNRNPAB SLC27A4 SYNCRIP

3.24e-141442842435575683
Pubmed

The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.

KRT3 TRAP1 DSTN P2RX3 AP2A1 AP2A2 CDK12 DCTN2 RPS3 RABGAP1L OSBPL1A HTATSF1 HMGB1 SRP72 HMGB3 EFHB HNRNPAB SYNCRIP

2.47e-101153841829845934
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

DSTN P2RX3 AP2A1 ANK3 AP2A2 SACS MYO9A DCTN2 RPS3 STRN4 HMGB1 SRP72 DAPK3 CNKSR2 DCLK2 HNRNPAB DCLK1 SYNCRIP

7.40e-091431841837142655
Pubmed

Aurora B opposes PP1 function in mitosis by phosphorylating the conserved PP1-binding RVxF motif in PP1 regulatory proteins.

BRCA1 ASPM SFI1 MPHOSPH10

5.64e-081684429764992
Pubmed

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.

TRAP1 BCAP31 DSTN ZMPSTE24 AP2A1 ANK3 AP2A2 RPS3 UGGT1 HMGB1 IDH1 RYR1 SYNCRIP

7.06e-08807841330575818
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

TRAP1 DSTN AP2A1 ANK3 AP2A2 UBE2L3 CDK12 DCTN2 RPS3 UGGT1 HMGB1 HMGB3 IDH1 HNRNPAB SYNCRIP

9.77e-081149841535446349
Pubmed

Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.

DSTN AP2A1 ANK3 AP2A2 UBE2L3 MYO9A MYO9B RPS3 SRP72 PSME2 NEB HNRNPAB SYNCRIP

1.18e-07844841325963833
Pubmed

The nuclear transcription factor RARalpha associates with neuronal RNA granules and suppresses translation.

AP2A1 AP2A2 RPS3 HNRNPAB SYNCRIP

2.10e-075484518495661
Pubmed

A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.

STK10 KRT3 SP100 TRAP1 DNAJC17 CDK12 ASPM HMGB1 MPHOSPH10 HNRNPAB

2.17e-07472841038943005
Pubmed

Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.

LARP4B TRAP1 AP2A1 AP2A2 MYO9A MYO9B RPS3 HNRNPAB SLC27A4 SYNCRIP

2.84e-07486841030940648
Pubmed

RNA binding proteins co-localize with small tau inclusions in tauopathy.

DSTN AP2A1 DCTN2 RPS3 SRP72 DCLK2 DCLK1 SYNCRIP

4.45e-0728384830068389
Pubmed

The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin.

LARP4B AP2A1 AP2A2 UBE2L3 SACS HMGB1 HNRNPAB SLC27A4 SYNCRIP

5.54e-0740084935013556
Pubmed

Interaction proteomics of the HMGA chromatin architectural factors.

HMGB1 HMGB3 HNRNPAB SYNCRIP

1.08e-063284418850631
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

BCAP31 DSTN AP2A1 AP2A2 MYO9B DCTN2 RPS3 HMGB1 SRP72 MPHOSPH10 IDH1 PSME2 ZNF281 SYNCRIP

1.65e-061247841427684187
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

KRT3 SP100 LARP4B DSTN AP2A1 RPS3 UGGT1 HMGB1 SRP72 DAPK3 MPHOSPH10 HNRNPAB CBX8 SYNCRIP

1.81e-061257841436526897
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

SP100 TRAP1 DCTN2 RPS3 UGGT1 NAP1L5 STRN4 HTATSF1 SRP72 HMGB3 IDH1 PSME2 WNK1 HNRNPAB SYNCRIP

1.92e-061455841522863883
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

AP2A1 SACS CDK12 RPS3 ANXA7 HMGB1 SRP72 HMGB3 PPIP5K2 ZNF281 HNRNPAB CBX8 SYNCRIP

1.93e-061082841338697112
Pubmed

A protein interaction landscape of breast cancer.

DSTN BRCA1 AP2A1 ANK3 AP2A2 UGGT1 IDH1 CBX8 SLC27A4 SYNCRIP

3.10e-06634841034591612
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

BRCA1 CDK12 RPS3 HTATSF1 HMGB1 SRP72 HMGB3 MPHOSPH10 ZNF281 HNRNPAB CBX8 SYNCRIP

3.12e-06954841236373674
Pubmed

Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity.

AP2A1 AP2A2 RPS3 ANXA7 HMGB1 SYNCRIP

3.23e-0616684627160897
Pubmed

Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.

LARP4B TRAP1 DSTN AP2A2 UBE2L3 DCTN2 HMGB1 IDH1 PSME2 SYNCRIP

4.73e-06665841030457570
Pubmed

PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.

LARP4B AP2A1 AP2A2 CDK12 RPS3 SRP72 MPHOSPH10 ZNF281 HNRNPAB SYNCRIP

5.60e-06678841030209976
Pubmed

Hmg4, a new member of the Hmg1/2 gene family.

HMGB1 HMGB3

5.76e-0628429598312
Pubmed

Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells.

BRCA1 AR

5.76e-06284211016951
Pubmed

Nanoscale increases in CD2-CD48-mediated intermembrane spacing decrease adhesion and reorganize the immunological synapse.

CD2 CD48

5.76e-06284218826951
Pubmed

CAG repeat length in exon 1 of the androgen receptor gene is related to age of diagnosis but not germ line BRCA1 mutation status in ovarian cancer.

BRCA1 AR

5.76e-06284216515589
Pubmed

Cloning of cDNAs encoding two related 100-kD coated vesicle proteins (alpha-adaptins).

AP2A1 AP2A2

5.76e-0628422564002
Pubmed

Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients.

ANK3 AR

5.76e-06284227534968
Pubmed

HMGB1 promotes the development of castration‑resistant prostate cancer by regulating androgen receptor activation.

HMGB1 AR

5.76e-06284236129149
Pubmed

Direct measurements of heterotypic adhesion between the cell surface proteins CD2 and CD48.

CD2 CD48

5.76e-06284212356317
Pubmed

Sequential cooperation of CD2 and CD48 in the buildup of the early TCR signalosome.

CD2 CD48

5.76e-06284219494291
Pubmed

Doublecortin-like kinase enhances dendritic remodelling and negatively regulates synapse maturation.

DCLK2 DCLK1

5.76e-06284223385585
Pubmed

Androgen receptor variant 12 promotes migration and invasion by regulating MYLK in gastric cancer.

MYLK AR

5.76e-06284230737779
Pubmed

Class IX Myosins: Motorized RhoGAP Signaling Molecules.

MYO9A MYO9B

5.76e-06284232451867
Pubmed

ZIP kinase plays a crucial role in androgen receptor-mediated transcription.

DAPK3 AR

5.76e-06284218084323
Pubmed

Regulation of CD2-mediated heterotypic interactions of murine T lymphocytes.

CD2 CD48

5.76e-0628427912994
Pubmed

Cis interactions between CD2 and its ligands on T cells are required for T cell activation.

CD2 CD48

5.76e-06284235930657
Pubmed

The abnormal spindle-like, microcephaly-associated (ASPM) gene encodes a centrosomal protein.

BRCA1 ASPM

5.76e-06284216123590
Pubmed

Increased RLIP76 expression in IDH1 wild‑type glioblastoma multiforme is associated with worse prognosis.

RALBP1 IDH1

5.76e-06284231746408
Pubmed

Cloning, physical mapping and structural characterization of the human alpha(A)-adaptin gene.

AP2A1 AP2A2

5.76e-06284212036598
Pubmed

Lethal multiple pterygium syndrome, large cystic hygroma, and cleft palate: Rare and severe fetal presentations of RYR1- and NEB-related congenital myopathies.

NEB RYR1

5.76e-06284238520674
Pubmed

The Deubiquitinating Enzyme USP48 Interacts with the Retinal Degeneration-Associated Proteins UNC119a and ARL3.

DSTN AP2A2 DCTN2 RPS3 HMGB1 IDH1 ALDH3A1 HNRNPAB SYNCRIP

7.67e-0655284936293380
Pubmed

BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.

TRAP1 MYLK RPS3 HMGB1 SRP72 IDH1 PSME2 HNRNPAB CBX8 SYNCRIP

8.47e-06711841033022573
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

LARP4B TRAP1 DSTN AP2A2 DCTN2 ANXA7 UGGT1 HMGB1 SRP72 PSME2 IFIT3 HNRNPAB SLC27A4 SYNCRIP

8.59e-061440841430833792
Pubmed

A receptor for activated C kinase is part of messenger ribonucleoprotein complexes associated with polyA-mRNAs in neurons.

LARP4B HNRNPAB SYNCRIP

9.02e-061784312388589
Pubmed

Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.

DSTN MYLK AP2A1 AP2A2 UBE2L3 CDK12 PSME2 WNK1 GALNT16 HNRNPAB

1.06e-05730841034857952
Pubmed

Identification and selected reaction monitoring (SRM) quantification of endocytosis factors associated with Numb.

AP2A1 AP2A2 RALBP1

1.08e-051884323211419
Pubmed

Functional proteomics mapping of a human signaling pathway.

DSTN AP2A1 ANK3 AP2A2 CDK12 HTATSF1 SRP72 MPHOSPH10 DENND2B

1.32e-0559184915231748
Pubmed

TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.

STK10 TRAP1 MYO9B DCTN2 MYLIP OSBPL1A STRN4 HMGB1 MPHOSPH10 HNRNPAB SYNCRIP

1.36e-05922841127609421
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

LARP4B AP2A1 MYO9B CDK12 ASPM SRP72 MPHOSPH10 HNRNPAB CBX8 SYNCRIP

1.49e-05759841035915203
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

TRAP1 AP2A1 ANK3 AP2A2 DCTN2 RABGAP1L OSBPL1A EXOC6B HMGB1 PPIP5K2 WNK1 DCLK1 SYNCRIP

1.65e-051321841327173435
Pubmed

Clathrin-independent endocytic retrieval of SV proteins mediated by the clathrin adaptor AP-2 at mammalian central synapses.

AP2A1 AP2A2

1.73e-05384235014951
Pubmed

A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2.

AP2A1 AP2A2

1.73e-05384218032517
Pubmed

The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series.

BRCA1 AR

1.73e-05384211221880
Pubmed

Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer.

HMGB1 HMGB3

1.73e-05384231621076
Pubmed

Genetic variation of some aldehyde-oxidizing enzymes in the mouse.

IDH1 ALDH3A1

1.73e-053842742739
Pubmed

CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.

BRCA1 AR

1.73e-05384211437399
Pubmed

BRCA1 inhibits AR-mediated proliferation of breast cancer cells through the activation of SIRT1.

BRCA1 AR

1.73e-05384226902145
Pubmed

Crystal structure and binding properties of the CD2 and CD244 (2B4)-binding protein, CD48.

CD2 CD48

1.73e-05384216803907
Pubmed

Suppression of adaptive NK cell expansion by macrophage-mediated phagocytosis inhibited by 2B4-CD48.

CD2 CD48

1.73e-05384238386559
Pubmed

AP2 adaptor complex mediates bile salt export pump internalization and modulates its hepatocanalicular expression and transport function.

AP2A1 AP2A2

1.73e-05384222262466
Pubmed

Envelope Glycoprotein Internalization Protects Human and Simian Immunodeficiency Virus-Infected Cells from Antibody-Dependent Cell-Mediated Cytotoxicity.

AP2A1 AP2A2

1.73e-05384226269175
Pubmed

CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation.

CD2 CD48

1.73e-0538421383383
Pubmed

BRCA1 or CDK12 loss sensitizes cells to CHK1 inhibitors.

BRCA1 CDK12

1.73e-05384229025359
Pubmed

Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype.

BRCA1 AR

1.73e-05384212404104
Pubmed

Androgen pathway dysregulation in BRCA1-mutated breast tumors.

BRCA1 AR

1.73e-05384212779088
Pubmed

A basic patch on alpha-adaptin is required for binding of human immunodeficiency virus type 1 Nef and cooperative assembly of a CD4-Nef-AP-2 complex.

AP2A1 AP2A2

1.73e-05384219129443
Pubmed

Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers.

BRCA1 AR

1.73e-05384219818997
Pubmed

Interaction of Shc with adaptor protein adaptins.

AP2A1 AP2A2

1.73e-0538428617812
Pubmed

Doublecortin-Like Kinases Promote Neuronal Survival and Induce Growth Cone Reformation via Distinct Mechanisms.

DCLK2 DCLK1

1.73e-05384226526391
Pubmed

Hmgb1 can facilitate activation of the matrilin-1 gene promoter by Sox9 and L-Sox5/Sox6 in early steps of chondrogenesis.

MATN1 HMGB1

1.73e-05384223860260
Pubmed

Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor.

BRCA1 AR

1.73e-05384211085509
Pubmed

Androgen receptor, EGFR, and BRCA1 as biomarkers in triple-negative breast cancer: a meta-analysis.

BRCA1 AR

1.73e-05384225695063
Pubmed

Alternative transcripts of Dclk1 and Dclk2 and their expression in doublecortin knockout mice.

DCLK2 DCLK1

1.73e-05384218075264
Pubmed

The ear of alpha-adaptin interacts with the COOH-terminal domain of the Eps 15 protein.

AP2A1 AP2A2

1.73e-0538428662627
Pubmed

A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration Reveals New Mechanisms of Redox Homeostasis and NF-κB Signaling.

TRAP1 DSTN UBE2L3 DCTN2 ANXA7 HMGB1 SRP72 HMGB3 PSME2 HNRNPAB

2.01e-05786841029128334
Pubmed

Diverse functions of myosin VI elucidated by an isoform-specific α-helix domain.

AP2A1 AP2A2 DCTN2

2.02e-052284326950368
Pubmed

USP45 and Spindly are part of the same complex implicated in cell migration.

FCHSD2 TRAP1 RPS3 UGGT1 STRN4 WNK1

2.34e-0523584630258100
Pubmed

A human MAP kinase interactome.

SP100 ANK3 MYO9A DCTN2 ANXA7 NAP1L5 NEB WNK1

2.36e-0548684820936779
Pubmed

Defining the membrane proteome of NK cells.

LARP4B TRAP1 BCAP31 ZMPSTE24 AP2A1 MYO9B RPS3 ANXA7 CD48 PSME2 SLC27A4 SYNCRIP

2.37e-051168841219946888
Pubmed

Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase.

TRAP1 DCTN2 RPS3 UGGT1 HTATSF1 SRP72 HNRNPAB SYNCRIP

2.69e-0549584828581483
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

DNAJC17 DSTN AP2A1 AP2A2 UBE2L3 RPS3 UGGT1 HTATSF1 SRP72 PSME2 WNK1 HNRNPAB SYNCRIP

3.37e-051415841328515276
Pubmed

Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing.

HNRNPAB SYNCRIP

3.45e-05484211134005
Pubmed

RLIP76, an effector of the GTPase Ral, interacts with the AP2 complex: involvement of the Ral pathway in receptor endocytosis.

AP2A2 RALBP1

3.45e-05484210910768
Pubmed

Disruption of the murine Ap2β1 gene causes nonsyndromic cleft palate.

AP2A1 AP2A2

3.45e-05484220500056
Pubmed

BIG1 is a binding partner of myosin IXb and regulates its Rho-GTPase activating protein activity.

MYO9A MYO9B

3.45e-05484215644318
Pubmed

The X-linked intellectual disability gene product and E3 ubiquitin ligase KLHL15 degrades doublecortin proteins to constrain neuronal dendritogenesis.

DCLK2 DCLK1

3.45e-05484233199366
Pubmed

Activation segment dimerization: a mechanism for kinase autophosphorylation of non-consensus sites.

STK10 DAPK3

3.45e-05484218239682
Pubmed

Receptors and counterreceptors involved in NK-B cell interactions.

CD2 CD48

3.45e-05484215778370
Pubmed

The B cell coreceptor CD22 associates with AP50, a clathrin-coated pit adapter protein, via tyrosine-dependent interaction.

AP2A1 AP2A2

3.45e-05484212646615
Pubmed

T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.

CD2 CD48

3.45e-05484216049493
Pubmed

Association and colocalization of Eps15 with adaptor protein-2 and clathrin.

AP2A1 AP2A2

3.45e-0548429049247
Pubmed

Ovarian cancer and polymorphisms in the androgen and progesterone receptor genes: a HuGE review.

BRCA1 AR

3.45e-05484214769635
Pubmed

CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells.

MYLIP AR

3.45e-05484229707137
Pubmed

Docking motif-guided mapping of the interactome of protein phosphatase-1.

SACS SFI1 MPHOSPH10 WNK1

4.35e-058084419389623
Pubmed

SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.

TRAP1 DSTN ZMPSTE24 AP2A1 AP2A2 CDK12 DCTN2 RPS3 HTATSF1 IDH1

5.11e-05878841037223481
Pubmed

Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.

DCTN2 STRN4 HTATSF1 HMGB1 HMGB3 WNK1 HNRNPAB

5.26e-0539984735987950
Pubmed

Profiling of the BRCA1 transcriptome through microarray and ChIP-chip analysis.

BRCA1 AP2A1

5.74e-05584221880590
Pubmed

Interaction of HIV-1 Gag with the clathrin-associated adaptor AP-2.

AP2A1 AP2A2

5.74e-05584216139856
Pubmed

Zipper-interacting protein kinase is involved in regulation of ubiquitination of the androgen receptor, thereby contributing to dynamic transcription complex assembly.

DAPK3 AR

5.74e-05584223146908
InteractionHEXIM1 interactions

KRT3 TRAP1 DSTN AP2A1 AP2A2 CDK12 DCTN2 RPS3 RABGAP1L OSBPL1A HTATSF1 HMGB1 SRP72 HMGB3 HNRNPAB AR SYNCRIP

1.50e-079138317int:HEXIM1
InteractionIFI16 interactions

SP100 LARP4B ZMPSTE24 BRCA1 AP2A2 DCTN2 RPS3 RABGAP1L ASPM SRP72 MPHOSPH10 HNRNPAB AR SYNCRIP

1.19e-067148314int:IFI16
InteractionBAP1 interactions

TRAP1 DSTN BRCA1 AP2A1 ANK3 AP2A2 UBE2L3 MYO9B CDK12 DCTN2 RPS3 UGGT1 NAP1L5 HMGB1 HMGB3 IDH1 HNRNPAB AR SYNCRIP

1.20e-0613148319int:BAP1
InteractionMOV10 interactions

STK10 SP100 LARP4B BCAP31 BRCA1 AP2A2 MYO9A CDK12 RPS3 ANXA7 STRN4 HTATSF1 HMGB3 IDH1 IFIT3 HNRNPAB CBX8 SYNCRIP

4.34e-0612978318int:MOV10
InteractionTMOD4 interactions

MYO9A MYO9B IDH1 NEB

5.87e-0629834int:TMOD4
InteractionMCM2 interactions

DSTN BRCA1 AP2A1 ANK3 AP2A2 UBE2L3 MYO9A MYO9B RPS3 SRP72 PSME2 NEB HNRNPAB AR DCLK1 SYNCRIP

7.27e-0610818316int:MCM2
InteractionAAK1 interactions

AP2A1 AP2A2 DCTN2 RALBP1 PPIP5K2 WNK1

1.07e-05121836int:AAK1
InteractionBRD7 interactions

LARP4B TRAP1 BRCA1 AP2A1 AP2A2 MYO9A MYO9B RPS3 HNRNPAB AR SLC27A4 SYNCRIP

1.12e-056378312int:BRD7
InteractionREPS2 interactions

AP2A1 RALBP1 UGGT1 AR

1.13e-0534834int:REPS2
InteractionKCTD13 interactions

DSTN P2RX3 AP2A1 ANK3 AP2A2 SACS MYO9A DCTN2 RPS3 STRN4 HMGB1 SRP72 DAPK3 CNKSR2 DCLK2 HNRNPAB DCLK1 SYNCRIP

1.17e-0513948318int:KCTD13
InteractionDKK3 interactions

MYO9A MYO9B RPS3 ASPM IDH1

1.44e-0575835int:DKK3
InteractionUSP48 interactions

DNAJC17 DSTN BRCA1 AP2A2 DCTN2 RPS3 HMGB1 IDH1 ALDH3A1 HNRNPAB AR SYNCRIP

1.79e-056688312int:USP48
InteractionAGR2 interactions

TRAP1 BCAP31 DSTN ZMPSTE24 AP2A1 ANK3 AP2A2 RPS3 UGGT1 HMGB1 IDH1 ALDH3A1 RYR1 SYNCRIP

2.56e-059348314int:AGR2
InteractionNXF1 interactions

STK10 SP100 TRAP1 BCAP31 AP2A2 MYO9A DCTN2 RPS3 ANXA7 RABGAP1L STRN4 HMGB3 MPHOSPH10 IDH1 ZNF281 HNRNPAB SLC27A4

2.82e-0513458317int:NXF1
InteractionMAPT interactions

DSTN BRCA1 AP2A1 ANK3 AP2A2 DCTN2 RPS3 HTATSF1 SRP72 DCLK2 TTC9 PSME2 HNRNPAB DCLK1 SYNCRIP

4.64e-0511198315int:MAPT
InteractionCALM1 interactions

MYLK MYO9B DCTN2 STRN4 ASPM SFI1 IDH1 NEB WNK1 AR RYR1

5.05e-056268311int:CALM1
InteractionCEBPB interactions

LARP4B TRAP1 BCAP31 BRCA1 DCTN2 RPS3 ASPM HTATSF1 HMGB1 SRP72 HMGB3 MPHOSPH10 ZNF281 HNRNPAB AR CBX8 SYNCRIP

6.84e-0514438317int:CEBPB
InteractionCIT interactions

LARP4B TRAP1 BRCA1 AP2A1 AP2A2 UBE2L3 MYO9B RPS3 SRP72 DAPK3 MYOM2 MPHOSPH10 PSME2 POLN ZNF281 HNRNPAB SYNCRIP

7.26e-0514508317int:CIT
InteractionATXN1 interactions

SP100 LARP4B TRAP1 DSTN AP2A2 UBE2L3 DCTN2 HMGB1 MYOM2 IDH1 PSME2 WNK1 AR SYNCRIP

8.13e-0510398314int:ATXN1
InteractionWNK3 interactions

AP2A1 AP2A2 RALBP1 WNK1

8.35e-0556834int:WNK3
InteractionMAPK6 interactions

BCAP31 ANK3 UBE2L3 DCTN2 RPS3 ASPM PSME2 ZNF281 SLC27A4

1.44e-04474839int:MAPK6
InteractionTNIK interactions

DSTN AP2A1 ANK3 AP2A2 DCTN2 STRN4 CNKSR2 DCLK1

1.74e-04381838int:TNIK
InteractionYWHAQ interactions

BCAP31 BRCA1 MYO9A RPS3 HMGB1 DAPK3 DCLK2 PPIP5K2 NEB WNK1 DENND2B AR DCLK1 ARAP2

1.76e-0411188314int:YWHAQ
InteractionHECTD1 interactions

LARP4B AP2A1 UBE2L3 MYO9B CDK12 DCTN2 RPS3 ASPM SRP72 MPHOSPH10 HNRNPAB CBX8 SYNCRIP

1.83e-049848313int:HECTD1
InteractionZNF827 interactions

SP100 BRCA1 HMGB1

2.28e-0429833int:ZNF827
InteractionAGAP2 interactions

AP2A1 ANK3 AP2A2 SACS CNKSR2 DCLK1

2.31e-04210836int:AGAP2
InteractionRPS6 interactions

BRCA1 GVINP1 CDK12 RPS3 UGGT1 HMGB1 SRP72 MYOM2 MPHOSPH10 AR CBX8 SYNCRIP

2.33e-048748312int:RPS6
InteractionTTN interactions

BRCA1 ANXA7 HMGB1 MYOM2 NEB HNRNPAB RYR1

2.34e-04299837int:TTN
InteractionACTN4 interactions

SACS RPS3 HMGB1 HMGB3 NEB HNRNPAB AR SYNCRIP

2.42e-04400838int:ACTN4
InteractionEFTUD2 interactions

DNAJC17 DSTN BRCA1 AP2A1 AP2A2 UBE2L3 RPS3 UGGT1 HTATSF1 HMGB1 SRP72 PSME2 WNK1 HNRNPAB AR SYNCRIP

2.44e-0414498316int:EFTUD2
InteractionPPIA interactions

STK10 KRT3 SP100 TRAP1 DNAJC17 ANK3 CDK12 ANXA7 ASPM HMGB1 MPHOSPH10 HNRNPAB

2.70e-048888312int:PPIA
InteractionMYOM2 interactions

MYOM2 NEB RYR1

2.79e-0431833int:MYOM2
InteractionPARP1 interactions

LARP4B BRCA1 AP2A1 AP2A2 UBE2L3 SACS HMGB1 HMGB3 MPHOSPH10 ZNF281 HNRNPAB AR CBX8 SLC27A4 SYNCRIP

2.80e-0413168315int:PARP1
InteractionESD interactions

TRAP1 MYLK UBE2L3 AR

2.88e-0477834int:ESD
GeneFamilyMyosins, class IX

MYO9A MYO9B

1.08e-0526021103
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

BRCA1 SACS SFI1 MPHOSPH10 WNK1 RYR1

2.96e-05181606694
GeneFamilyDoublecortin superfamily

DCLK2 DCLK1

4.79e-04106021369
GeneFamilyCanonical high mobility group

HMGB1 HMGB3

5.84e-0411602511
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

BRCA1 SACS MYO9A RALBP1 RABGAP1L OSBPL1A ASPM HTATSF1 HMGB1 MPHOSPH10 PPIP5K2 PUS7L

1.05e-066568312M18979
ToppCellCOVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class

SP100 CD2 ANK3 RPS3 GOLGA8B SFI1 IFIT3

1.05e-07200847deeed668b129e66156b5f6abe1a07a9bf842a14d
ToppCell10x5'v1-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

COL6A6 WNT2 TTC9 OGN GALNT16 DCLK1

1.57e-06189846473b01c9162b12b90a617c600238436177a0d18d
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SP100 CD2 ANK3 GOLGA8B SFI1 IFIT3

1.77e-061938462901d7a9672a8cf70c9f1c752685b45e4d79ac70
ToppCellCOVID-19_Severe-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Severe / Disease group, lineage and cell class

SP100 CD2 ANK3 GOLGA8B SFI1 IFIT3

1.77e-06193846beb862d38b88572836b0a797c8efef7a2492e0b9
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SP100 CD2 ANK3 GOLGA8B SFI1 IFIT3

1.77e-06193846f4310faa13fc8ce99a217e2d1c9cc733683797a1
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SP100 CD2 ANK3 GOLGA8B SFI1 IFIT3

1.77e-06193846f8af695457d2a0a911a5ac491742465864ebda37
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

SP100 CD2 ANK3 GOLGA8B SFI1 IFIT3

1.77e-06193846089aece40130034a89a5213be778f10b0787eeba
ToppCellSevere-B_intermediate-10|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)

ANK3 CD48 MYOM2 NEB IFIT3 RYR1

2.06e-06198846dfae26c3513a82bb7cb8dadbfcea2a1f420b1bab
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SP100 CD2 RPS3 CD48 HMGB1 ARAP2

2.12e-061998468f2b57cf2f932f20ea029132d8bda01aac774571
ToppCellCOVID-19_Moderate-CD4+_CTL|COVID-19_Moderate / disease group, cell group and cell class

CD2 DSTN RPS3 CD48 MYOM2 ARAP2

2.18e-06200846a9c73559e2c9fda1b065bfb5ce84978995505924
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DSTN MYLK CNKSR2 MYOM2 OGN

1.76e-05170845cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DSTN MYLK CNKSR2 MYOM2 OGN

1.76e-05170845da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

SYCP2 ASPM MYOM2 OGN IFIT3

1.86e-0517284586f52f486d67217fc1b8443ab362c975df2974a4
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

SYCP2 ASPM MYOM2 OGN IFIT3

1.86e-05172845fb2df8fea6df5947165f13978f1d1006d15b60fd
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

SYCP2 ASPM MYOM2 OGN IFIT3

1.86e-05172845e38ebb216e4ddcd008148fcbaf709b4f3c83706a
ToppCell3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

AP2A1 ANK3 COL6A6 WNT2 OGN

2.14e-051778457af1a19692f7fe8f691178a4e57d62bc379e3d56
ToppCellSevere-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

ANK3 MYOM2 NEB IFIT3 RYR1

2.20e-05178845b7374a97c51239782bed658381a02cb1b3d9bf66
ToppCelldroplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SP100 GVINP1 CDK12 IFIT3 ARAP2

2.20e-0517884501dafd19de04eff459253eaa9a35debf8f3deedf
ToppCellChildren_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

ANK3 GOLGA8B HMGB3 ALDH3A1 AR

2.20e-05178845fba2e38c05cbf031e0c6d47b1602575fea734a57
ToppCellPND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SP100 CD2 RPS3 RABGAP1L CD48

2.32e-05180845b83d067dee641941c596e4a25d81327931b6ad61
ToppCellPND10-Immune|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

STK10 SP100 CD2 RPS3 CD48

2.38e-05181845ef424f7eefe1b190a2be2ebcae7652eb8e7ba883
ToppCell3'_v3-bone_marrow-Lymphocytic_T_CD4-Tfh|bone_marrow / Manually curated celltypes from each tissue

CD2 ANK3 RPS3 CD48 TTC9

2.44e-05182845c059e79da49db3649052581d95255f03e2956144
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SYCP2 CNKSR2 MYOM2 SFI1 NEB

2.57e-051848452cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SYCP2 CNKSR2 MYOM2 SFI1 NEB

2.57e-05184845ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SYCP2 CNKSR2 MYOM2 SFI1 NEB

2.57e-051848452b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL6A6 WNT2 OGN GALNT16 DCLK1

2.57e-051848454d4d8f3f44c67d74c57e7af7b7c158f0157b2f49
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD2 RPS3 MYLIP CD48 HMGB1

2.64e-05185845f60b39010b9210a5f18ccd113758512bd15d7eec
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CD2 GPR149 ASPM AR INPP5J

2.71e-051868456379609b7ace80683f5754b16aa77f11b43766ae
ToppCellLA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

ANK3 RABGAP1L EXOC6B MYOM2 NEB

2.85e-051888456d249fe92d51a19da19ec14bb2262d394255d577
ToppCell10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

COL6A6 WNT2 OGN GALNT16 DCLK1

2.93e-05189845eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0
ToppCell10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

COL6A6 WNT2 OGN GALNT16 DCLK1

2.93e-0518984540764f461b8aa1d3a2c5a30590b7fb9307d47d09
ToppCellCOVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations)

STK10 CD2 ANK3 RABGAP1L ARAP2

3.08e-051918457f64add931b64b8d35836fa6bee9ebab593844d3
ToppCell10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

COL6A6 WNT2 OGN GALNT16 DCLK1

3.16e-051928454ed5040594ba2d0639f0990697504ecef872ca70
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD2 ANXA7 ASPM HMGB3 HNRNPAB

3.16e-05192845694626965faee8b7c4e5bb78d554f62ba8dbc423
ToppCell10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

COL6A6 WNT2 OGN GALNT16 DCLK1

3.16e-05192845d4f5d6653564c2c5d0f5f7c932d89cb1b1412844
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DSTN MYLK COL6A6 OGN GALNT16

3.16e-0519284526d9207e72bbef5e0046de511e2c9ff752b726f3
ToppCellCV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster

SP100 CD2 CD48 PSME2 IFIT3

3.16e-051928452a2052b44e8f679ef484f03ba4fb37b0ec841b88
ToppCellCOVID-19_Moderate-CD4+_T_activated|COVID-19_Moderate / disease group, cell group and cell class

SP100 CD2 ANK3 MYLIP IFIT3

3.16e-051928457a81652406332afd03a9b3b529e9b5e6c0b54c28
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DSTN MYLK COL6A6 OGN GALNT16

3.23e-051938457fc3ab7261c88c1df71744bf5b17e8e46c4300e0
ToppCell10x5'v1-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

COL6A6 WNT2 OGN GALNT16 DCLK1

3.23e-051938453d85c28f6ebdcb15e875ad01d52d6c138fbf8525
ToppCell10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

COL6A6 WNT2 OGN GALNT16 DCLK1

3.23e-0519384509de51f8ac509e03d480ed3dc9dfe7e7defc59cb
ToppCellPCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung

RPS3 ASPM DAPK3 HMGB3 HNRNPAB

3.32e-051948455759c83308df017f1faae248e9b85388e25254f0
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CD2 RPS3 CD48 HMGB1 ARAP2

3.32e-05194845bf2480acec5612cd8a3c33d3e7a98176dc6c9091
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

STK10 FCHSD2 AP2A2 MYO9B RYR1

3.32e-0519484545708cb2cafde10bf4e4798b81d47c3b1f6aaa14
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

MYLK COL6A6 WNT2 OGN AR

3.40e-0519584570387a62f121f8c374dba1aca9ab65cfed6a0b10
ToppCellnormal_Pleural_Fluid|World / Location, Cell class and cell subclass

SP100 CD2 RPS3 CD48 HMGB1

3.48e-051968457029c9f4a826f6cfdcb5f7a472fba94e8945a771
ToppCellIPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class

MYLK COL6A6 WNT2 OGN DCLK1

3.48e-051968457fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7
ToppCellControl-Non-classical_Monocyte-|Control / Disease condition and Cell class

AP2A1 RABGAP1L TTC9 IFIT3 ARAP2

3.48e-05196845b17ab094cdc7050c2997e24ed474779b5d6f6146
ToppCellIPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class

MYLK COL6A6 WNT2 OGN DCLK1

3.48e-051968452d0a48e49b3b37bb66e33e74c52915911e1f8a74
ToppCell10x3'2.3-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

COL6A6 WNT2 OGN GALNT16 DCLK1

3.48e-05196845ee45e4de9d706ec87094e87f47d3e514539b8092
ToppCell10x3'2.3-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

COL6A6 WNT2 OGN GALNT16 DCLK1

3.48e-05196845fa4a85a3cd52df0da5dfedc0e584e9df8c61ce89
ToppCellControl-Non-classical_Monocyte|Control / Disease condition and Cell class

AP2A1 RABGAP1L TTC9 IFIT3 ARAP2

3.48e-05196845404064ccfe2cb73df7a7f88aa65d86b97dcef9d4
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CD2 ANK3 GVINP1 RPS3 GOLGA8B

3.48e-051968454a880a5d2c7047c050c7d6dd62186f35dc5c01f7
ToppCell10x5'-blood-Lymphocytic_T_CD4/8-lo-Cycling_T|blood / Manually curated celltypes from each tissue

BRCA1 ASPM HMGB1 HMGB3 HNRNPAB

3.57e-051978451f7c3d193647b66cce6ea202a40758cd10b8bd12
ToppCell10x5'-blood-Lymphocytic_T_CD4/8-lo|blood / Manually curated celltypes from each tissue

BRCA1 ASPM HMGB1 HMGB3 HNRNPAB

3.57e-05197845acd678586aa0e4375bc8fbcdaa1a796c8dd23885
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

MYLK COL6A6 WNT2 CNKSR2 OGN

3.57e-051978450034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

MYLK COL6A6 WNT2 CNKSR2 OGN

3.57e-0519784511a4c417f035e554431a8f03be13b5eefa3530c0
ToppCellICU-NoSEP-Lymphocyte-T_NK|ICU-NoSEP / Disease, Lineage and Cell Type

CD2 DSTN RPS3 HMGB1 MYOM2

3.57e-05197845951bb4c1e6f5c5fd7e7d58b36eb3f31e9201fb66
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CD2 DSTN RPS3 CD48 MYOM2

3.65e-05198845f77f21f21566a04145217ebf85cd14db48945056
ToppCell10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

BRCA1 ASPM HMGB1 HMGB3 HNRNPAB

3.65e-051988452e669da80363163b806f23a645474d482797ae5d
ToppCellMild-CD8+_T_activated|Mild / Disease group and Cell class

SP100 CD48 PSME2 IFIT3 ARAP2

3.65e-05198845ceac1b51bacfd0dd7fe7c6a666f7927055e1f380
ToppCelldroplet-Limb_Muscle-nan-24m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANK3 RPS3 NAP1L5 TTC9 ALDH3A1

3.65e-05198845d5e91d1057e71b6a336eec95e44b2e7fe6b2c6ef
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CD2 DSTN RPS3 CD48 MYOM2

3.65e-051988457f61a9a3d61992c023cc4bc4571a0a7a1a160833
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CD2 DSTN RPS3 CD48 MYOM2

3.65e-05198845d3d117dc3c2a533365bd2d1a6ab0c60e976d2c10
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_CTL|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CD2 DSTN RPS3 CD48 MYOM2

3.65e-05198845ed39ac9d4b1f50e9086ace3ad3325db0d5f4c323
ToppCell3'_v3-bone_marrow-Hematopoietic_progenitors|bone_marrow / Manually curated celltypes from each tissue

BRCA1 OSBPL1A HMGB1 HMGB3 HNRNPAB

3.65e-0519884531e5b842d87f599b3d43447b8c11fcdb8f94d047
ToppCellmild_COVID-19_(asymptomatic)-CD4+_CTL|World / disease group, cell group and cell class (v2)

SP100 CD2 DSTN MYOM2 ARAP2

3.65e-0519884503c01fc384d46eec55ff730edbab8a3fde618ed8
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SP100 ANK3 GOLGA8B SFI1 ARAP2

3.74e-05199845f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCellVE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster

SP100 ANK3 CD48 PSME2 IFIT3

3.74e-05199845056a0538ca5e825ae6195b4c76c208708a014533
ToppCellwk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

DSTN MYLK WNT2 CNKSR2 OGN

3.74e-051998456bce8e65859a35cfea1c210f9c9765952d492ed2
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class

CD2 WNK1 OGN IFIT3 ARAP2

3.74e-05199845f307d4887b28cf60a591439e278fd668409cb104
ToppCell343B-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells)

BRCA1 ASPM HMGB1 HMGB3 HNRNPAB

3.83e-052008455f2fbd789cc16af411a01c3199583888b260ae91
ToppCell356C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells)

BRCA1 ASPM HMGB1 HMGB3 HNRNPAB

3.83e-05200845548a0f486ab8745da107f2815914dbf873a6e3c8
ToppCellTransverse-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass

BRCA1 OSBPL1A ASPM HMGB1 HMGB3

3.83e-05200845617a6a42f7b31eb3c45bdceaf55a591b6de7f154
ToppCellSepsis-ICU-NoSEP-Lymphocyte-T/NK|ICU-NoSEP / Disease, condition lineage and cell class

CD2 DSTN RPS3 HMGB1 MYOM2

3.83e-0520084531c06b73292015e69038e52ae67322f458f37c71
ToppCellMS-IIF-Lymphocyte-T/NK-CD8+_Tcm|IIF / Disease, condition lineage and cell class

CD2 ANK3 RPS3 CD48 HMGB1

3.83e-0520084501554c0b7b8d7a12d99853fe057a20ed775ee5b2
ToppCellVE|World / Condition, Cell_class and T cell subcluster

SP100 PSME2 IFIT3 HNRNPAB ARAP2

3.83e-052008458ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_CTL|COVID-19_Mild / Disease, condition lineage and cell class

CD2 DSTN RPS3 CD48 MYOM2

3.83e-0520084511fd7eca2fa399ec3d7f9556d09e07c886cc9e83
ToppCellLPS-antiTNF-Lymphocytic_NKT-T_cells-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CD2 MATN1 NAP1L5 STRN4

9.51e-0512684454247ce9ee0a4f123f1fb225600a4ec698510a86
ToppCellfacs-Skin-Anagen-24m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RPS3 MYLIP OGN GALNT16

1.35e-04138844e8faf333553273b68a10b01470bb43a0383d6212
ToppCellfacs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAD51AP2 P2RX3 BRCA1 MATN1

1.86e-0415084447ea08d7609e1d2382bf56ef9e5c767e3597cf93
ToppCellPND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SP100 CD2 MATN1 CD48

1.86e-04150844c18d3f66b384ec9ee0b8fb6a369b9a524b5dcaeb
ToppCell368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|368C / Donor, Lineage, Cell class and subclass (all cells)

CD2 RPS3 CD48 SFI1

1.91e-0415184472c47ed207951e73ef6c72085b2a3f48a99be952
ToppCellMS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster

SP100 PSME2 IFIT3 DCLK1

1.96e-04152844b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ASPM CNKSR2 INPP5J PUS7L

2.11e-041558448b524c65fa5c901f70c7caae4ec7fd2859eaf227
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD2 COL6A6 NAP1L5 OGN

2.11e-041558447aba8ef53c9170ad8ed955c904c8991097ab1e32
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ASPM CNKSR2 INPP5J PUS7L

2.11e-041558447fe8b8c0c8a9e3190cfd52d3934509e6780e1717
ToppCellCOVID-19_Moderate-multiplets|World / disease group, cell group and cell class

GOLGA8B MYOM2 SFI1 ARAP2

2.16e-04156844afdc025fa75e7926b1cc182c4a33654a2186abb1
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD2 BRCA1 CBX8 SLC27A4

2.16e-04156844fbe23876f0899853cea3c5c4f3044a9cea064d5b
ToppCellPND07-28-samps|World / Age Group, Lineage, Cell class and subclass

STK10 CD2 GVINP1 CD48

2.22e-04157844a2005768a6d268879e3fd6dbd8cf674dc98be587
ToppCellPND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DSTN MYLK OGN GALNT16

2.38e-041608448624f101828efd32cdd38a65df8d94d690720a63
ToppCellPND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DSTN MYLK OGN GALNT16

2.38e-041608449de3dd6b9d4b51314d60b3b01f4132bcfa2dfc18
ToppCellP07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_mature_unknown_2|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

STK10 FMO4 WNT2 ANXA7

2.38e-0416084468b477525eeef99430382ff0a6745cac91364bc2
ToppCellfacs-Pancreas-Exocrine-18m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STK10 SP100 CYP8B1 CD48

2.44e-0416184416f77e7a5444d2f2b210362816cd7a07b9b42af6
ToppCellfacs-Pancreas-Exocrine-18m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STK10 SP100 CYP8B1 CD48

2.44e-04161844f5821f551cf5c64c9f75cdb723492c87aac1ece0
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9

FCHSD2 HTATSF1 STOX1 RYR1

2.44e-04161844347edb0de10850b7d16c40945751033289289c9b
ToppCellfacs-Pancreas-Exocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STK10 SP100 CYP8B1 CD48

2.44e-0416184458a32a1033f379579697bda1bbf047a088e4a34f
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYLK CYP8B1 HMGB1 HMGB3

2.62e-0416484472ef807895385ba23e30d19d12b1b0549a699690
ToppCell3'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HMGB1 STOX1 POLN IFIT3

2.74e-04166844b64ab3d13b76bba3c305ebbfc96f983cd6ca30c9
ToppCelldroplet-Thymus-nan-3m-Lymphocytic-DN4|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD2 RPS3 PSME2 IFIT3

2.80e-0416784410c9fab3573c2948081aac2cec1798e46e59e38a
DrugMethylcholanthrene

FCHSD2 SYCP2 MYLK BRCA1 UBE2L3 ASPM CD48 MYOM2 ALDH3A1 ZNF281 OGN IFIT3 HNRNPAB DCLK1 SYNCRIP

4.37e-0610348315ctd:D008748
DrugLanatoside C [17575-22-3]; Down 200; 4uM; MCF7; HT_HG-U133A

SP100 LARP4B DNAJC17 BRCA1 SACS IDH1 PUS7L

4.97e-061848373852_DN
DrugColistin sulfate [1264-72-8]; Down 200; 3uM; MCF7; HT_HG-U133A

STK10 SYCP2 OSBPL1A NEB DENND2B AR INPP5J

7.52e-061968372851_DN
DrugOndansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; PC3; HT_HG-U133A

LARP4B DCTN2 RABGAP1L TTC9 NEB AR CBX8

7.77e-061978375796_UP
Diseasedyslexia (implicated_via_orthology)

DCLK2 DCLK1

7.44e-062812DOID:4428 (implicated_via_orthology)
Diseaserestrictive dermopathy (implicated_via_orthology)

ZMPSTE24 SLC27A4

2.23e-053812DOID:0060762 (implicated_via_orthology)
DiseaseProgeria

ZMPSTE24 ANK3

7.40e-055812C0033300
DiseaseMULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE

NEB RYR1

1.11e-046812C1854678
Diseasemigraine disorder

STK10 LARP4B DSTN GPR149 RABGAP1L CNKSR2

4.55e-04357816MONDO_0005277
Diseaseniacinamide measurement

FMO4 OSBPL1A

4.83e-0412812EFO_0010511
DiseaseCongenital myopathy (disorder)

NEB RYR1

4.83e-0412812C0270960
Diseasexanthine measurement

MATN1 CNKSR2

5.69e-0413812EFO_0010548
DiseaseProstate cancer, familial

LARP4B BRCA1 MYO9B

9.16e-0469813C2931456
DiseaseAdenocarcinoma of prostate

BRCA1 AR

1.37e-0320812C0007112
DiseaseAnaplastic astrocytoma

IDH1 AR

2.50e-0327812C0334579

Protein segments in the cluster

PeptideGeneStartEntry
KQDALDFKKDKGAFY

CDK12

796

Q9NYV4
KSLKEFYGEDAKKSR

ALDH3A1

266

P30838
ETFKEKDTYKLFKNG

CD2

76

P06729
RSNLEEKYQKKFAGK

GVINP1

2386

Q7Z2Y8
RSKFKGDKALDGYSK

AP2A1

41

O95782
RKNFITQKYKEGKFR

ARAP2

786

Q8WZ64
QKIKAAFKTSYGKDL

ANXA7

221

P20073
NAAYDKFKDKRVGTK

DCTN2

51

Q13561
IYASSKDAIKKKFQG

DSTN

116

P60981
KRTFEYEADKNPKSK

DENND2B

391

P78524
KKKGKRDSGSFEQYS

ASPM

1096

Q8IZT6
RSKFKGDKALDGYSK

AP2A2

41

O94973
FLQKYKKIKDFARAA

POLN

711

Q7Z5Q5
GVQSYKSKFKAKEPR

C16orf46

331

Q6P387
KGFDEKAYLSAKQLK

GALNT16

66

Q8N428
KKNDKKEAYVRDFTN

RAD51AP2

281

Q09MP3
KKKEKRTEGYAAFQE

RALBP1

76

Q15311
AGKFFKAYSAKEKEN

MYLK

1491

Q15746
YINDAAKKAKDLGFK

MATN1

391

P21941
TAADDKQPYEKKAAK

HMGB1

136

P09429
FKKKYEDEINKRTAA

KRT3

286

P12035
KNSFGYRKKREEKFT

LARP4B

496

Q92615
FKKQAESASEAAKKY

BCAP31

136

P51572
SSEKKAKKVRFYRNG

DCLK1

51

O15075
SSEKKAKKARFYRNG

DCLK2

66

Q8N568
FGKLERVKKLKDYAF

SYNCRIP

361

O60506
YLNKDNEGFKCKKSD

FAM214A

726

Q32MH5
KRGVFKDTSKDKFDY

FMO4

416

P31512
RQKGTGKEYAAKFIK

DAPK3

31

O43293
NLGKKYVFDIKRTSK

MYLIP

306

Q8WY64
YNKIKSRGIKANAFK

OGN

196

P20774
KSGKSSRNLKYKDFF

MPHOSPH10

256

O00566
KVFFKRAAEGKQKYL

AR

581

P10275
GSKRKSKKDAYIIFD

EXOC6B

241

Q9Y2D4
TFDAYKKNDKKNTEE

OSBPL1A

786

Q9BXW6
KDRDKFYFKLKQGIE

RABGAP1L

296

Q5R372
AKFQLKGEYDASKKK

HTATSF1

216

O43719
NAYAVASDGKKIKRK

GPR149

381

Q86SP6
IEDKIFGKTYRKKAS

BRCA1

456

P38398
TKNTILKKYDGRFKD

IDH1

211

O75874
LKAQAKAKAKTYEFR

CBX8

81

Q9HC52
SAAKFYRRKGDLDKA

IFIT3

246

O14879
LTNLKYKFEDAKKDG

ANK3

2046

Q12955
AAARAAYDKVRKAKK

DNAJC17

66

Q9NVM6
GAKFVSKRADDFKEK

EFHB

476

Q8N7U6
DVADYKSKGKFDGAK

HMGB3

156

O15347
KDLAKGKKKYFETEQ

FCHSD2

146

O94868
GQSKLAAAKKKFKEY

GOLGA8B

6

A8MQT2
FQADAFAKKLGKAKD

ZMPSTE24

416

O75844
SRKSKYFESKFKGRV

CD48

71

P09326
IREKKQEFCEKNYGK

SACS

2436

Q9NZJ4
KDATTEKNKKRGFLF

RYR1

1376

P21817
KAKFFQDKKYLSRVA

COL6A6

2216

A6NMZ7
KDTQRKLDFGQYAKK

CYP8B1

91

Q9UNU6
FLKGADQYKAKKFEE

P2RX3

346

P56373
KKVDSRYFKDGAVKK

SFI1

26

A8K8P3
SKKDLKDYFTKFGEV

HNRNPAB

81

Q99729
FDFFKYLDAKKENSK

PUS7L

216

Q9H0K6
AKFDKEFQALEKKYN

NAP1L5

96

Q96NT1
SKKRKFVADGIFKAE

RPS3

6

P23396
KYFSERGDAVAKASK

PSME2

166

Q9UL46
REAANFKLKYGRKKE

SRP72

451

O76094
EYMFQRNSKKDTGKK

CNKSR2

481

Q8WXI2
DVGTNKYDTSAKKRK

INPP5J

661

Q15735
KFARAFVDAKERKGK

WNT2

166

P09544
KKIAKDVFKKGDQAY

SLC27A4

471

Q6P1M0
FCKNAEEFTKKYGEK

UBE2L5

136

A0A1B0GUS4
LRKAFDDIAKYFSKK

SSX4

21

O60224
YTRDKEKGKKFGFSL

STOX1

301

Q6ZVD7
IQKAFDDIAKYFSKK

SSX9P

21

Q7RTT3
EFAKPSKYIKNSDKG

SYCP2

446

Q9BX26
AFGKVYKAKNKETGA

STK10

46

O94804
AAADKQFYEKKAAKL

SP100

811

P23497
IFKKGSRKNTDKNYL

ZNF281

466

Q9Y2X9
FIDQSKKDAEKYAKF

TRAP1

426

Q12931
KQERAKYHKLKFGTD

STRN4

126

Q9NRL3
KLEKDFKTKNGRYDI

PPIP5K2

706

O43314
KLKGKYKDNEAIEFS

WNK1

511

Q9H4A3
RFQKEKETGALYKEK

UGGT1

1526

Q9NYU2
AEEYSKDRKKFCKNA

UBE2L3

126

P68036
FCKNAEEFTKKYGEK

UBE2L3

136

P68036
KSQGAQCYKDKKFRE

TTC9

61

Q92623
KVKYGVKDFREKNTD

MYO9A

656

B2RTY4
FAGKVKYQIKDFREK

MYO9B

636

Q13459
KDKGKYTFEIFDGKD

MYOM2

1296

P54296
SQVKYRENFDKEKGK

NEB

5791

P20929